Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Jul;58(1):137–141. doi: 10.1172/JCI108442

Effect of salicylates on histamine and L-histidine metabolism. Inhibition of imidazoleacetate phosphoribosyl transferase.

J Moss, M C De Mello, M Vaughan, M A Beaven
PMCID: PMC333164  PMID: 180057

Abstract

In man and other animals, urinary excretion of the histidine and histamine metabolite, imidazoleacetate, is increased and that of its conjugated metabolite, ribosylimidazoleacetate, decreased by salicylates. Imidazoleacetate has been reported to produce analgesia and narcosis. Its accumulation as a result of transferase inhibition could play a part in the therapeutic effects of salicylates. To determine the locus of salicylate action, we have investigated the effect of anti-inflammatory drugs on imidazoleacetate phosphoribosyl transferase, the enzyme that catalyzes the ATP-dependent conjugation of imidazoleacetate with phosphoribosylpyrophosphate. As little as 0.2 mM aspirin produced 50% inhibition of the rat liver transferase. In vivo, a 30% decrease in the urinary excretion of ribosylimidazoleacetate has been observed with plasma salicylate concentrations of 0.4 mM. The enzyme was also inhibited by sodium salicylate but not by salicylamide, sodium gentisate, aminopyrine, phenacetin, phenylbutazone, or indomethacin. The last four drugs have been shown previously not to alter the excretion of ribosylimidazoleacetate when administered in vivo. Since both the drug specificity and inhibitory concentrations are similar in vivo and in vitro, it seems probable that the effect of salicylates on imidazoleacetate conjugation results from inhibition of imidazoleacetate phosphoribosyl transferase.

Full text

PDF
137

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWN D. D., SILVA O. L., McDONALD P. B., SNYDER S. H., KIES M. W. The mammalian metabolism of L-histidine. III. The urinary metabolites of L-histidine-C14 in the monkey, human, and rat. J Biol Chem. 1960 Jan;235:154–159. [PubMed] [Google Scholar]
  2. Beaven M. A., Horakova Z., Keiser H. Inhibition by aspirin of ribose conjugation in the metabolism of histamine. Eur J Pharmacol. 1974 Nov;29(1):138–146. doi: 10.1016/0014-2999(74)90180-0. [DOI] [PubMed] [Google Scholar]
  3. Benton D., Kyriacou C. P., Rick J. T., Taberner P. V. Behavioural interactions between imidazoleacetic acid and gamma-hydroxybutyric acid in rats and mice. Eur J Pharmacol. 1974 Aug;27(3):288–293. doi: 10.1016/0014-2999(74)90003-x. [DOI] [PubMed] [Google Scholar]
  4. COOPER J. A., SCHAYER R. W. Metabolism of C14 histamine in man. J Appl Physiol. 1956 Nov;9(3):481–483. doi: 10.1152/jappl.1956.9.3.481. [DOI] [PubMed] [Google Scholar]
  5. CROWLEY G. M. THE ENZYMATIC SYNTHESIS OF 5'-PHOSPHORIBOSYLIMIDAZOLEACETIC ACID. J Biol Chem. 1964 Aug;239:2593–2601. [PubMed] [Google Scholar]
  6. Crout J. E., Hepburn B., Ritts R. E., Jr Suppression of lymphocyte transformation after aspirin ingestion. N Engl J Med. 1975 Jan 30;292(5):221–223. doi: 10.1056/NEJM197501302920501. [DOI] [PubMed] [Google Scholar]
  7. Davison C. Salicylate metabolism in man. Ann N Y Acad Sci. 1971 Jul 6;179:249–268. doi: 10.1111/j.1749-6632.1971.tb46905.x. [DOI] [PubMed] [Google Scholar]
  8. Dawkins P. D., Gould B. J., Smith M. J. Inhibitory effect of salicylate on the incorporation of L-(U-14C)leucine into the protein of rat tissue preparations in vitro. Biochem J. 1966 Jun;99(3):703–707. doi: 10.1042/bj0990703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FERNANDES J. F., CASTELLANI O., PLESE M. Biosynthesis of histamine ribotide and imidazoleacetate ribotide. Biochem Biophys Res Commun. 1960 Dec;3:679–684. doi: 10.1016/0006-291x(60)90086-3. [DOI] [PubMed] [Google Scholar]
  10. Flower R. J., Vane J. R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972 Dec 15;240(5381):410–411. doi: 10.1038/240410a0. [DOI] [PubMed] [Google Scholar]
  11. Flower R., Gryglewski R., Herbaczyńska-Cedro K., Vane J. R. Effects of anti-inflammatory drugs on prostaglandin biosynthesis. Nat New Biol. 1972 Jul 26;238(82):104–106. doi: 10.1038/newbio238104a0. [DOI] [PubMed] [Google Scholar]
  12. Ku E. C., Wasvary J. M., Cash W. D. Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase. Biochem Pharmacol. 1975 Mar 1;24(5):641–643. doi: 10.1016/0006-2952(75)90186-0. [DOI] [PubMed] [Google Scholar]
  13. Opelz G., Terasaki P. I., Hirata A. A. Suppression of lymphocyte transformation by aspirin. Lancet. 1973 Sep 1;2(7827):478–480. doi: 10.1016/s0140-6736(73)92073-4. [DOI] [PubMed] [Google Scholar]
  14. Pachman L. M., Esterly N. B., Peterson R. D. The effect of salicylate on the metabolism of normal and stimulated human lymphocytes in vitro. J Clin Invest. 1971 Jan;50(1):226–230. doi: 10.1172/JCI106478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rosenberg F. J., Gimber-Phillips P. E., Groblewski G. E., Davison C., Phillips D. K., Goralnick S. J., Cahill E. D. Acetylsalicylic acid: inhibition of platelet aggregation in the rabbit. J Pharmacol Exp Ther. 1971 Nov;179(2):410–418. [PubMed] [Google Scholar]
  16. Roth G. J., Majerus P. W. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975 Sep;56(3):624–632. doi: 10.1172/JCI108132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SCHAYER R. W. The metabolism of histamine in various species. Br J Pharmacol Chemother. 1956 Dec;11(4):472–473. doi: 10.1111/j.1476-5381.1956.tb00020.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Schwartz C. S., Mandel H. G. The selective inhibition of microbial RNA synthesis by salicylate. Biochem Pharmacol. 1972 Mar 15;21(6):771–785. doi: 10.1016/0006-2952(72)90121-9. [DOI] [PubMed] [Google Scholar]
  19. Sturman J. A., Dawkins P. D., McArthur N., Smith M. J. The distribution of salicylate in mouse tissues after intraperitoneal injection. J Pharm Pharmacol. 1968 Jan;20(1):58–63. doi: 10.1111/j.2042-7158.1968.tb09619.x. [DOI] [PubMed] [Google Scholar]
  20. WOLFF J., AUSTEN F. K. Salicylates and thyroid function. II. The effect on the thyroid-pituitary interrelation. J Clin Invest. 1958 Aug;37(8):1144–1152. doi: 10.1172/JCI103704. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES